To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension
Clinical trial NCT07191899 · RECRUITING
Trial details
- NCT number
- NCT07191899
- Sponsor
- Suzhou Alphamab Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-05
- Primary completion
- 2026-12-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.